WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.

Sporting Events Dominate The Opening Weekend of Spring
Temperatures Move Up The Rest of the Week
Impeachment Process of Forsyth Mayor Continues
NCCAA National Basketball Tournament Begins Wednesday
Eureka Springs City Council Member Arrested For Incidents in 2025